Immunohistochemical expression of leptin in non melanoma skin cancer

Show simple item record

dc.contributor.author Farag A.G.A.
dc.contributor.author Elnaidany N.F.
dc.contributor.author El-Dien M.M.S.
dc.contributor.other Department of Dermatology and Andrology
dc.contributor.other Faculty of Medicine
dc.contributor.other Menoufia University
dc.contributor.other Egypt; Department of Clinical Pharmacy
dc.contributor.other MSA October University
dc.contributor.other Egypt; Department of Pathology
dc.contributor.other Faculty of Medicine
dc.contributor.other Menoufia University
dc.contributor.other Egypt
dc.date.accessioned 2020-01-09T20:41:35Z
dc.date.available 2020-01-09T20:41:35Z
dc.date.issued 2016
dc.identifier.issn 2249782X
dc.identifier.other https://doi.org/10.7860/JCDR/2016/19755.8385
dc.identifier.other PubMed ID :
dc.identifier.uri https://t.ly/YZWED
dc.description Scopus
dc.description MSA Google Scholar
dc.description.abstract Introduction: Obesity in adults is associated with numerous health disorders including some forms of cancer. Various epidemiological studies have found a link between excess adiposity and malignant melanoma; however, the association with non melanoma skin cancer is questionable. Leptin is a hormone produced mainly by the adipose tissue and its serum level may reflect body mass index. Leptin is reported to promote proliferation and angiogenesis and deregulate apoptosis, therefore facilitates the process of carcinogenesis. Aim: The current study tried to assess leptin localization and expression in non melanoma skin cancer to verify its possible role in pathogenesis of this cancer. Materials and Methods: This study was carried out on 13 Basal Cell Carcinoma (BCC) cases and 14 Squamous Cell Carcinoma (SCC) cases together with 19 normal skin biopsies as a control group using immunohistochemical method. Results: Leptin was expressed in 52.6% of the normal epidermis with pure cytoplasmic and both cytoplasmic and nuclear staining patterns. All cases of SCC (100%) and two cases of BCC (15.4%) showed leptin expression in tumour cells whereas nuclear expression was in favour of SCC. Stromal expression of leptin was seen in both SCC (57.1%) and BCC (38.5%) without significant differences. Percentage of leptin expression by tumour cells in SCC showed positive linear correlation with tumour size (p=0.02) and microvessel density (p=0.000). Stromal expression of leptin in SCC was associated with large tumour size (p=0.04), advanced stage (p=0.01) and tumours arising in sites other than head and neck (p=0.01). Conclusion: Leptin could have a more important role in pathogenesis of cutaneous SCC rather than BCC that may reflect the trivial role of obesity in induction of BCC. The expression of leptin by tumour and stromal cells of SCC could co-operate in its progression by promoting angiogenesis with subsequently acquiring large tumour size and then advanced stage. � 2016, Journal of Clinical and Diagnostic Research. All rights reserved. en_US
dc.description.uri https://www.scimagojr.com/journalsearch.php?q=16400154778&tip=sid&clean=0
dc.language.iso English en_US
dc.publisher Journal of Clinical and Diagnostic Research en_US
dc.relation.ispartofseries Journal of Clinical and Diagnostic Research
dc.relation.ispartofseries 10
dc.subject Basal cell carcinoma en_US
dc.subject Obesity en_US
dc.subject Squamous cell carcinoma en_US
dc.subject leptin en_US
dc.subject adolescent en_US
dc.subject adult en_US
dc.subject aged en_US
dc.subject angiogenesis en_US
dc.subject Article en_US
dc.subject basal cell carcinoma en_US
dc.subject body mass en_US
dc.subject capillary density en_US
dc.subject cell proliferation en_US
dc.subject child en_US
dc.subject clinical article en_US
dc.subject clinical assessment en_US
dc.subject controlled study en_US
dc.subject disease association en_US
dc.subject female en_US
dc.subject human en_US
dc.subject human tissue en_US
dc.subject immunohistochemistry en_US
dc.subject male en_US
dc.subject melanoma skin cancer en_US
dc.subject middle aged en_US
dc.subject obesity en_US
dc.subject protein expression en_US
dc.subject skin biopsy en_US
dc.subject squamous cell carcinoma en_US
dc.subject tumor volume en_US
dc.title Immunohistochemical expression of leptin in non melanoma skin cancer en_US
dc.type Article en_US
dcterms.isReferencedBy Ahima, R.S., Flier, J.S., (2000) Leptin. Annu Rev Physiol, 62, pp. 413-437; Malik, K.F., Young, W.S., Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice (1996) Endocrinology, 137, pp. 1497-1500; Cinti, S., De Matteis, R., Pico, C., Ceresi, E., Obrador, A., Maffeis, C., Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin (2000) Int J Obes Relat Metab Disord, 24, pp. 789-793; Leone, A., Spatola, G.F., Cucco, D., Tessitore, V., Bonaventura, G., Uzzo, M.L., Immunohistochemical expression and distribution of orexin, orphanin and leptin in the major salivary glands of some mammals (2012) Folia Histochem Cytobiol, 50, pp. 504-512; Hoggard, N., Hunter, L., Duncan, J.S., Williams, L.M., Trayhurn, P., Mercer, J.G., Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta (1997) Proc Natl Acad Sci USA, 94, pp. 11073-11078; Smith-Kirwin, S.M., O�Connor, D.M., De Johnston, J., Lancey, E.D., Hassink, S.G., Funanage, V.L., Leptin expression in human mammary epithelial cells and breast milk (1998) J Clin Endocrinol Metab, 83, pp. 1810-1813; Bonaventura, G., Cucco, D., Spatola, G.F., Leptin immunohistochemical expression in rat respiratory system (2009) Eperimental Medicine Reviews, 2-3, p. 57. , Gerbino A, Zummo G, Cresciamanno G, editors, Palermo: Plumelia; Bj�rbaek, C., Kahn, B.B., Leptin signaling in the central nervous system and the periphery (2004) Recent Prog Horm Res, 59, pp. 305-331; Okumura, M., Yamamoto, M., Sakuma, H., Kojima, T., Maruyama, T., Jamali, M., Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: Reciprocal involvement of PKC-alpha and PPAR expression (2002) Biochim Biophys Acta, 1592, pp. 107-116; Garofalo, C., Surmacz, E., Leptin and cancer (2006) J Cell Physiol, 207, pp. 12-22; Klein, S., Wadden, T., Sugerman, H.J., AGA technical review on obesity (2002) Gastro-Enterology, 123, pp. 882-932; Samanic, C., Gridley, G., Chow, W.H., Lubin, J., Hoover, R.N., Fraumeni, J.F., Jr., Obesity and cancer risk among white and black United States veterans (2004) Cancer Causes Control, 15, pp. 35-43; Dennis, L.K., Lowe, J.B., Lynch, C.F., Alavanja, M.C., Cutaneous melanoma and obesity in the agricultural health study (2008) Ann Epidemiol, 18, pp. 214-221; Veierod, M.B., Thelle, D.S., Laake, P., Diet and risk of cutaneous malignant melanoma: A prospective study of 50,757 Norwegian men and women (1997) Int J Cancer, 71, pp. 600-604; Courneya, K.S., Katzmarzyk, P.T., Bacon, E., Physical activity and besity in Canadian cancer survivors: Population-based estimates from the 2005 Canadian Community Health Survey (2008) Cancer, 112, pp. 2475-2482; Olsen, C.M., Hughes, M.C., Pandeya, N., Green, A.C., Anthropometric measures in relation to basal cell carcinoma: A longitudinal study (2006) BMC Cancer, 6, p. 82; Lin, J., Yan, G., Roles of leptin-mediated intracellular signaling pathways on wound healing (2007) Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 21, pp. 1254-1258; Seleit, I., Bakry, O.A., Samaka, R.M., Samy, M., Immunohistochemical evaluation of leptin role in skin tags (2015) Ultrastructural Pathology, 39 (4), pp. 235-244; Rico, L., Del Rio, M., Bravo, A., Ramirez, A., Jorcano, J.L., Page, M.A., Targeted overexpression of leptin to keratinocytes in transgenic mice results in lack of skin phenotype but induction of early leptin resistance (2005) Endocrinology, 146, pp. 4167-4176; Murad, A., Nath, A.K., Cha, S.T., Demir, E., Flores-Riveros, J., Sierra-Honigmann, M.R., Leptin is an autocrine ? paracrine regulator of wound healing (2003) FASEB J, 17, pp. 1895-1897; Glasow, A., Kiess, W., Eregg, U., Berthold, A., Bottner, A., Kratzsch, J., Expression of leptin (Ob) and leptin receptor (Ob-R) in human fibroblasts: Regulation of leptin secraetion by insulin (2001) J Clin Endocrinol Metab, 86, pp. 4472-4479; Cerman, A.A., Bozkurt, S., Sav, A., Tulunay, A., Elbas, M.O., Ergun, T., Serum leptin levels, skin leptin and leptin receptor expression in psoriasis (2008) Br J Dermatol, 159, pp. 820-826; Johnston, A., Arnadotti, S., Gudjonsson, J.E., Aphale, A., Sigmarsdottir, A.A., Gunnarsson, S.I., Obesity in psoriasis: Leptin and resistin as mediators of cutaneous inflammation (2008) Br J Dermatol, 159, pp. 342-350; Cao, Y., Gao, F., Li, C.Z., Xue, Y.M., Expression of leptin and its long-form receptor in the marginal cutaneous tissues of diabetic foot ulcers (2012) Acta Diabetol, 49, pp. S205-S214; Liapakis, I.E., Anagnostoulis, S., Karayiannakis, A., Karayiannakis, A., Korkolis, D.P., Lambropoulou, M., Recombinant leptin administration improves early angiogenesis in full-thickness skin flaps: An experimental study (2008) In Vivo, 22, pp. 247-252; Stallmeyer, B., Kampfer, H., Podda, M., Kaufmann, R., Pfeilschifter, J., Frank, S., A novel keratinocyte mitogen: Regulation of leptin and its functional receptor in skin repair (2001) J Invest Dermatol, 117, pp. 98-105; Ezure, T., Amano, S., Adiponectin and leptin up-regulate extracellular matrix production by dermal fibroblasts (2007) Biofactors, 31, pp. 229-236; Wang, Q.Y., Shen, Z.X., The expression and value of leptin and leptin receptor in human esophageal carcinoma (2012) Laboratory Medicine, 43, pp. 1-5; Gallina, S., Sireci, F., Lorusso, F., Di Benedetto, D.V., Speciale, R., Marchese, D., The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinoma (2015) Acta Otorhinolaryngol Ital, 35, pp. 15-22; Kim, Y.J., Kim, Y.S., Chin, S., Yoon, J.S., Lee, S.Y., Kim, C.Y., Cytoplasmic and nuclear leptin expression in lacrimal gland tumours: A pilot study (2015) Br J Ophthalmol, 99, p. 1306; Sano, S., Chan, K.S., Digiovanni, J., Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases (2008) J Dermatol Sci, 50, pp. 1-14; Sharma, S.D., Katiyar, S.K., Leptin deficiency-induced obesity exacerbates ultraviolet B radiation-induced cyclooxygenase-2 expression and cell survival signals in ultraviolet B-irradiated mouse skin (2010) Toxicol Appl Pharmacol, 244, pp. 328-335; Mukhtar, H., Elmets, C., Photocarcinogenesis: Mechanisms, models and human health implications (1996) Photochem Photobiol, 63, pp. 356-357; Scott, K., Moore, R., Arnott, C., East, N., Thompson, R.G., Scallon, B.J., An antitumour necrosis factor-alpha antibody inhibits the development of experimental skin tumours (2003) Mol Cancer Ther, 2, pp. 445-451; Pothiawala, S., Qureshi, A.A., Li, Y., Han, J., Obesity and the incidence of skin cancer in US Caucasians (2012) Cancer Causes Control, 23, pp. 717-726; Ellerhorst, J.A., Diwan, A.H., Dang, S.M., Uffort, D.G., Johnson, M.K., Cooke, C.P., Promotion of melanoma growth by the metabolic hormone leptin (2010) Oncol Rep, 23, pp. 901-907; Carroll, K.K., Obesity as a risk factor for certain types of cancer (1998) Lipids, 33, pp. 1055-1059
dcterms.source Scopus
dc.identifier.doi https://doi.org/10.7860/JCDR/2016/19755.8385
dc.identifier.doi PubMed ID :
dc.Affiliation October University for modern sciences and Arts (MSA)


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MSAR


Advanced Search

Browse

My Account